Literature DB >> 7636503

Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5'noncoding region.

S Diedrich1, G Driesel, E Schreier.   

Abstract

The genetic relationship between echovirus type 30 (E30) isolates were characterised by means of amplification of a part of the 5'noncoding region by polymerase chain reaction and direct sequencing. Later, the E30 sequences were compared with other enteroviruses. Homology between recent clinical E30 isolates from different years exceeds 98% at the nucleotide level. Comparing the E30 sequence with other enteroviruses, homology varied between 68% (coxsackievirus A24) and 93% (coxsackievirus B3). E30 appeared to have coxsackie B-like characteristics in this genomic part. It is considered that E30 and coxsackie B viruses belong to the same enterovirus subgroup.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636503     DOI: 10.1002/jmv.1890460212

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.

Authors:  M S Oberste; K Maher; M L Kennett; J J Campbell; M S Carpenter; D Schnurr; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Identification of enteroviruses by using monoclonal antibodies against a putative common epitope.

Authors:  Soo-Youn Shin; Ki-Soon Kim; Yoon-Sung Lee; Yoon-Seok Chung; Kwi-Sung Park; Doo-Sung Cheon; Byoung-Kuk Na; Yoonsung Kang; Hyang-Min Cheong; Youngjoon Moon; Jee-Hye Choi; Hang-Eui Cho; Na-Young Min; Jin-Sook Son; Young-Hoon Park; Youngmee Jee; Jae-Deuk Yoon; Chul-Yong Song; Kwang-Ho Lee
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Typing of human enteroviruses by partial sequencing of VP1.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M R Flemister; B A Brown; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Classification and structure of echovirus 5'-UTR sequences.

Authors:  Nikolaos Siafakas; Dimitrios Papaventsis; Stamatina Levidiotou-Stefanou; Nicholas C Vamvakopoulos; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Complete genome sequence analysis of human echovirus type 30 isolated in China.

Authors:  Jian-Feng Han; Li-Juan Xu; Rui-Yuan Cao; Hui Zhao; Tao Jiang; Yong-Qiang Deng; Yue-Xiang Li; Shun-Ya Zhu; Man Yu; E-De Qin; Cheng-Feng Qin
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

7.  An echovirus 30 outbreak with a high meningitis attack rate among children and household members at four day-care centers.

Authors:  U C Vieth; M Kunzelmann; S Diedrich; H Timm; A Ammon; O Lyytikäinen; L R Petersen
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

8.  Molecular epidemiology of Echovirus 30 in Taiwan, 1988-2008.

Authors:  Guan-Ming Ke; Kuei-Hsiang Lin; Po-Liang Lu; Yi-Chin Tung; Chu-Feng Wang; Liang-Yin Ke; Min-Sheng Lee; Pei-Chin Lin; Hui-Ju Su; Yi-Ying Lin; Tzu-Ping Huang; Jen-Ren Wang; Sheng-Yu Wang; Li-Ching Hsu; Pei-Yu Chu
Journal:  Virus Genes       Date:  2011-01-08       Impact factor: 2.332

9.  Intratypic genome variability of echovirus type 30 in part of the VP4/VP2 coding region.

Authors:  K Gjøen; A L Bruu; I Orstavik
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Early Entry Events in Echovirus 30 Infection.

Authors:  Helena Vandesande; Mira Laajala; Tino Kantoluoto; Visa Ruokolainen; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.